Delivery Order SPE2DB24D2101-SPE2DB26FKFBL
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,406.92 to AmerisourceBergen Drug Corp for LONSURF 20 mg-8.19 mg tablets (quantity 20) on October 20, 2025, with completion expected by November 10, 2025. This is a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of LONSURF (20 mg-8.19 mg tablets, 60-count packages) with a ceiling value of $10,173.33. This competitively awarded, non-set-aside contract is scheduled for completion by September 30, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,539.15 to AmerisourceBergen Drug Corp for LONSURF 15 mg-6.14 mg tablets (20-count units) on September 25, 2025, with an ultimate completion date of October 17, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is the place of performance for this delivery order, which represents a single transaction under the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of LONSURF (15 mg-6.14 mg tablets) in a quantity of 40 units, with a ceiling value of $5,124.17 and firm fixed pricing. This delivery order, which is not set-aside, is scheduled for completion by August 28, 2025, with performance occurring at the vendor's location in Conshohocken, Pennsylvania. The award represents a competitive procurement under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order valued at $3,406.92 to AmerisourceBergen Drug Corp for LONSURF 20 mg-8.19 mg tablets (20-count packaging), with completion targeted for November 13, 2025. This is a firm fixed price, non-set-aside contract awarded on October 22, 2025, with performance to be fulfilled at the vendor's facility in Conshohocken, Pennsylvania. The delivery order represents a competitively awarded transaction under AmerisourceBergen's broader contractual...
- The Defense Logistics Agency awarded a $30,519.99 firm fixed-price delivery order to AmerisourceBergen Drug Corp for LONSURF (20 mg-8.19 mg tablets, 60-count packages) on September 22, 2025, with an ultimate completion date of October 14, 2025. This delivery order was awarded competitively without set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $13,520.28 to AmerisourceBergen Drug Corp for the supply of LONSURF (20 mg-8.19 mg tablets) in quantities of 40 units. This competitive award, issued on May 30, 2025, with an ultimate completion date of June 23, 2025, represents a firm fixed-price delivery order with no set-aside designation. The product will be delivered to the company's location in Conshohocken, Pennsylvania. This award is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Lonsurf (15 mg-6.14 mg tablets, 40-count packages) with a ceiling value of $5,124.17 and firm fixed pricing. This competitively awarded, non-set-aside contract is scheduled for completion by October 17, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order under...
- The Defense Logistics Agency awarded a delivery order valued at $10,173.33 to AmerisourceBergen Drug Corp for the supply of Lonsurf (20 mg-8.19 mg tablets, quantity 60) under a firm fixed price contract type. The award, issued on September 2, 2025, with an ultimate completion date of September 23, 2025, represents a non-set-aside competitive procurement. This delivery order is executed under AmerisourceBergen's Indefinite Delivery Contract (IDC) designated SPE2DX with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $6.76K to AmerisourceBergen Drug Corp for the supply of LONSURF 20 mg–8.19 mg tablets (40-count packages). This non-competitive, firm fixed-price delivery order was issued on June 16, 2025, with an ultimate completion date of July 9, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. LONSURF is a combination chemotherapy medication used in cancer treatment, reflecting the breadth of...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB26FKFBLDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for LONSURF (20 mg-8.19 mg tablets, 20-count) on October 22, 2025, with a ceiling value of $6,813.86 and an ultimate completion date of November 13, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a continuation of the company's extensive pharmaceutical supply relationship with the federal government. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this delivery order. This award is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply medications, medical devices, and healthcare commodities to military healthcare programs worldwide. As a major pharmaceutical distributor serving the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, AmerisourceBergen maintains a significant portfolio of delivery orders across multiple therapeutic domains, with this LONSURF order representing a routine pharmaceutical procurement supporting the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.8k | 10/22/25 |